TC, H., KE, K., GH, T., N, Z., S, L., A, S., . . . BA, D. (2004). Intravenous administration of an AAV-2 vector for the expression of factor IX in mice and a dog model of hemophilia B. Gene therapy, 11(2), 204. https://doi.org/10.1038/sj.gt.3302142
Chicago Style (17th ed.) CitationTC, Harding, et al. "Intravenous Administration of an AAV-2 Vector for the Expression of Factor IX in Mice and a Dog Model of Hemophilia B." Gene Therapy 11, no. 2 (2004): 204. https://doi.org/10.1038/sj.gt.3302142.
MLA (9th ed.) CitationTC, Harding, et al. "Intravenous Administration of an AAV-2 Vector for the Expression of Factor IX in Mice and a Dog Model of Hemophilia B." Gene Therapy, vol. 11, no. 2, 2004, p. 204, https://doi.org/10.1038/sj.gt.3302142.
Warning: These citations may not always be 100% accurate.